Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?

Obesity Surgery

Volumn 14, Issue 7, 2004, Pages 999-1005

  Frezza, Ermenegildo Eldo ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Acyl CoA; Bariatric surgery; Diabetes; Ghrelin; GIP; GLP 1; Incretins; Lypolysis; Morbid obesity; YY3 36 (PYY)

Indexed keywords

ACYL COENZYME A; FATTY ACID; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; INSULIN RECEPTOR; PEPTIDE YY; UNCLASSIFIED DRUG;

BARIATRIC SURGERY; DIET RESTRICTION; DISEASE COURSE; FATTY ACID BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE RELEASE; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID STORAGE; LIPOLYSIS; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REACTION ANALYSIS; REVIEW; WEIGHT REDUCTION;

ACYL COENZYME A; DIABETES MELLITUS, TYPE 2; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONES; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; LIPOLYSIS; OBESITY, MORBID; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PEPTIDE YY; PROTEIN PRECURSORS;

EID: 4143059165     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892041719699     Document Type: Review

References (21)

1. United States Department of Health and Human Services. Health Implications of Obesity. National Institutes of Health Consensus Development Conference Summary, March 1991. WIN@matthews-group.com
2. Sjostrom L. Morbidity of severely obese subjects. Am J Clin Nutr 1992; 55: 508S-515S.
3. Sjostrom L. Mortality of severely obese subjects. Am J Clin Nutr 1992; 55: 516S-523S.
4. Scheen AJ. From obesity to diabetes: why, when and who? Acta Clin Belg 2000; 55: 9-15.
5. Webber J. Energy balance in obesity. Proc Nutr Soc. 2003; 62: 539-43.
6. Corkey BE, Deeney JT, Yaney GC et al. The role of long-chain fatty acyl-CoA esters in beta-cell signal transduction. J Nutr 2000; 130 (Suppl 2S): 299S-304S.
7. Larsson O, Deeney JT, Branstrom R et al. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. J Biol Chem 1996; 271: 10623-6.
8. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia 2003; 46: 1297-312. Epub 2003 Sep 12.
9. Creutzfeldt W. The entero-insular axis in type 2 diabetes - incretins as therapeutic agents. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S288-303.
10. Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003; 10: 2929-40.
11. Holz GG, Chepurny OG. Glucagon-like Peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus. Curr Med Chem 2003; 22: 2471-84.
12. Ahren B. Gut peptides and type 2 diabetes mellitus treatment. Curr Diab Rep 2003; 5: 365-72.
13. Meier JJ, Gallwitz B, Nauck MA. Glucagon-like Peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus. BioDrugs 2003; 17: 93-102.
14. Batterham RL, Cohen MA, Ellis SM et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003; 349: 941-8.
15. Haqq AM, Farooqi IS, O'Rahilly S et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 2003; 88: 174-8.
16. Frühbeck G, Diez-Cabellero A, Gil MJ et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 2004; 14: 606-12.
17. Geloneze B, Tambascia MA, Prilla VF et al. Ghrelin: a gut brain hormone: effect of gastric bypass surgery. Obes Surg 2003; 13: 17-22.
18. Adami GF, Cordera R, Marinari G et al. Plasma ghrelin concentration in short-term following biliopancreatic diversion. Obes Surg 2003; 13: 889-92.
19. Holdstock C, Engstrom BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177-83.
20. Leonetti F, Silecchia G, Iacobellis G et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrino Metab 2003; 88: 4227-31.
21. Frühbeck G, Diez-Cabellero A, Gomez-Ambrosi J et al. Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic silicone gastric banding.